M&A
Advisory

Transactions need a secure foundation. Crucial to both buyers and sellers: taking prompt, targeted action and having a direct line to decision makers.

Buyside Sellside Joint Ventures

IDENTIFY, CONTACT,
BUY

With over 200 international sell-side and buy-side transactions totalling in excess of 25 billion euros, goetzpartners is one of the most successful mid-market M&A firms. We leverage our sector expertise, network of contacts and many years of M&A experience into creating value for buy-side stakeholders. Alongside carving out the best possible position for buyers in the transaction process, goetzpartners services include efficient process execution, strategic valuation analysis, advice on financing, and support and coordination through the entire buy-side process.

Our expertise for buy-side transactions:

  • Strong market and industry expertise, including deep-dive market analysis
  • Identification of suitable target companies as per investment criteria
  • Development of a targeted communication and positioning strategy
  • Advice on carve-out transactions, also international transactions
  • Support with coordination of due diligence providers, with preparation of business plans and company valuations
  • Advice on acquisition and refinancing, including modeling

 

Our sector expertise

GAIN THE
OPTIMUM

goetzpartners represents the interests of companies from all key industries all over the world. With over twenty years of experience, we think like entrepreneurs and have direct access to the decision makers that matter – all this and more forms the basis for our extraordinary success. goetzpartners has talented people with years of expertise in every element of the process – from bilateral talks to vendor-optimized auctioning. The outcome: we can provide our clients with definite advantage in sell-side transactions that serve to optimize value or ensure long-term security, even in challenging situations.

Our expertise for sell-side transactions:

  • Best possible tactical preparation and execution of the sales process
  • Prompt preparation of documents and coordination of vendor due diligence advisers
  • In-depth sector expertise ensures potential buyers are identified quickly
  • Wide range of investors can be approached owing to international presence and strong network of contacts
  • Optimization of financial and structural terms of sale
  • Extensive expertise in carve-outs, especially for complex, international structures
  • goetzpartners approaches potential financial backers though “lender education” and obtains term sheets

 

Our sector expertise

PERFECT
MATCHMAKING

goetzpartners has many years of experience in preparing, initiating and executing mergers and Joint Ventures. We know how stakeholders need to design the strategy, business model and organization of their JV in order to derive maximum value. Our customers have an experienced partner at their side to navigate and resolve the challenging issues of governance, leadership and risk. Each joint venture has to be crafted such that the objectives of its stakeholders are met. This takes relevant technical expertise – but also familiarity with the sector in which the venture will be operating.

Our expertise for Joint Ventures:

  • Independent advisory for all types of planned Joint Ventures
  • Joint Ventures initiation and execution
  • Performance-optimized design of each Joint Ventures
  • Specialist knowledge in all key areas, including valuation, advice on corporate governance and structuring  

Our sector expertise

»

goetzpartners’ team has been pivotal to structure the operation and assist us in negotiating our partnership while following the right momentum. Throughout the process, goetzpartners has demonstrated outstanding commitment to the transaction and to the company’s interests.

«

Frédéric Bedin
Chairman of the Executive Board
HOPSCOTCH Groupe

Latest Transactions

  • Jul 2019 DEU DEU
    € 15.000.000
    goetzpartners was mandated by Vivoryon Therapeutics AG for
    STRATEGIC ADVICE
    on the option agreement and equity commitment for its lead compound to MorphoSys AG
  • May 2019 DEU USA
    (value not disclosed)
    goetzpartners advised the shareholders on the
    SALE
    of Vibalogics GmbH to Ampersand Capital Partners
  • Apr 2019 DEU USA
    (value not disclosed)
    goetzpartners advised MSX International (Bain Capital) on the
    ACQUISITION
    of a stake in MCON Group AG
  • Mar 2019 DEU DEU
    (value not disclosed)
    goetzpartners advised HQ Equita on the
    ACQUISITION
    of EBERTLANG from Beyond Capital Partners and its founding shareholders
  • Jan 2019 CHE CHE
    (value not disclosed)
    goetzpartners advised SoftwareONE - a KKR-backed company - on the
    ACQUISITION
    of COMPAREX

 GOETZPARTNERS ADVISED VIVORYON THERAPEUTICS AG ON THE OPTION AGREEMENT AND EQUITY COMMITMENT FOR ITS LEAD COMPOUND TO MORPHOSYS AG

VIVORYON THERAPEUTICS AG, the Germany-based clinical stage precision medicine company focused on novel therapies for age-related diseases, mandated goetzpartners as exclusive advisor on the option agreement of its small molecule inhibitors to MorphoSys AG, the clinical-stage biopharmaceutical company focused on the development of antibodies.

MorphoSys obtained an exclusive and worldwide option to license VIVORYON's small molecule QPCTL inhibitors in the field of oncology, including its lead compound PQ912. In exchange, MorphoSys has committed to investing up to EUR 15,000,000 in a minority stake in VIVORYON THERAPEUTICS as part of a capital raise planned for later this year. If MorphoSys chooses to exercise the option, VIVORYON THERAPEUTICS will further receive an option fee and is eligible for milestone payments and royalties. Read more
 

GOETZPARTNERS ADVISED THE SHAREHOLDERS ON THE SALE OF VIBALOGICS TO AMPERSAND CAPITAL PARTNERS

goetzpartners was mandated as exclusive M&A advisor on the sale of VIBALOGICS, a rapidly growing CDMO offering GMP-compliant manufacturing and development services for the international biopharmaceutical industry, to the US-based private equity firm Ampersand Capital Partners.

VIBALOGICS offers process development, manufacturing and fill & finish of products for biopharmaceutical companies involved in the development of oncolytic viral therapies, gene therapies, and vaccines. With a specific focus on viruses, live bacteria, and aseptic processing, the Company’s 50 employees work in full compliance with international GMP standards in a BSL-2 classified state-of-the-art, 27,000 sq. ft. facility in Cuxhaven, Germany. Read more

GOETZPARTNERS ADVISED MSX INTERNATIONAL ON ITS STRATEGIC INVESTMENT IN MCON GROUP AG

goetzpartners advised MSXI International ("MSXI") - a leading technology enabled business process outsourcing company that provides technology-based services to enterprises in more than 80 countries - on the strategic investment in the Germany-based MCON Group, a multinational digital professional and managed services organization. With this investment, MSXI strengthens its digitalization strategy and further expands its spectrum of capabilities in digital technologies and its focus for long-term growth and footprint expansion in China. MSXI and MCON are also committed on creating new solutions that will offer forward-thinking products and services to the automotive industry worldwide. Read more

GOETZPARTNERS WAS MANDATED BY HQ EQUITA FOR THE SUCCESSFUL ACQUISITION OF EBERTLANG USING ITS TRANSACTION ADVISORY SERVICES: M&A, DEBT ADVISORY & CDD SERVICES

HQ Equita, the Germany-based direct investment company of HQ Capital, mandated goetzpartners with M&A, Debt Advisory and CDD services on the acquisition of a majority interest in EBERTLANG, a leading value-added software distribution player, from Beyond Capital Partners and the company's founders.

Based in Wetzlar, Germany, EBERTLANG is one of the leading value-added distributors of infrastructure software for small and mid-sized companies in German-speaking Europe. The company provides software solutions for email archiving, back-up, IT-security, service automation and continuity, and also offers comprehensive training, consulting and service support to both partners and software vendors. Read more

GOETZPARTNERS ADVISED KKR-BACKED SOFTWAREONE ON THE ACQUISITION OF COMPAREX

goetzpartners advised SoftwareONE, a global leading platform, solutions and services company backed by the private equity investor KKR, on the acquisition of 100% of the shares in COMPAREX, a global IT service provider, from Raiffeisen Informatik.

By coming together, COMPAREX will enhance SoftwareONE’s customer offerings by combining industry leading talent, expertise and capabilities. Following the combination, SoftwareONE will help customers optimize and manage an estimated €10 bn in software purchases. The combined company will have an expanded global reach across 88 countries, allowing customers to receive on-the-ground, local-language support wherever they operate, from more than 5,500 employees. A comprehensive services and solutions portfolio, driven by proven and continued investment in innovation, will provide customers with more advanced solutions, including SoftwareONE’s PyraCloud, an industry-leading platform for digital software supply chain management. Read more

VIEW ALL TRANSACTIONS

M&A Advisory

About goetzpartners Corporate Finance

Brochure:

DOWNLOAD

PUBLICATION

Paving your path through Post-Merger Integration

The significance of continuous long-term restructuring activities is increasing again, especially in the context of persistent economic uncertainty. The problem is that within the company, these activities are frequently neither systematically established nor rigorously pursued. Instead of controlling the progress of measures actively, the organization simply reacts to events.

Wie kann man sich den Weg durch Post-Merger-Integrationen bahnen und welche Vorteile ergeben sich durch einen umfassenden, professionell geführten Ansatz? Welche Schritte sind nötig, um Organisationen wieder wettbewerbsfähig zu machen, und welche Dimensionen werden wann und wie am besten bearbeitet?

Read more

Medisorb

 

International investor found for family-run pharmaceutical company – Medisorb becomes Russia's largest maker of generic drugs

Case:

More on this project

Have a read!

Mergers & Acquisitions in China and Europe: 6 ways to make cross-border M&As a success

Chinese investors are as much on the lookout for profitable projects in Europe as European investors are in China. However, this can often involve risks. Six tips for Chinese and European companies to make sure everything goes smoothly.

We explore this issue in our online magazine Transformation Beats. The magazine reports on digital business models in practice: entrepreneurs, CxOs and managers experience live how changes are initiated and taken into action.

READ ARTICLE

Contact

Christian Muthler

Christian Muthler Managing Director
Corporate Finance
Industrials & Automotive

Ivo Polten

Ivo Polten Managing Director
Corporate Finance
Industrials & IT Services

Serge Prager

Serge Prager Managing Director
Corporate Finance
Head of France

Milan Saric

Milan Saric Managing Director
Corporate Finance
TMT, Carve-out situations